As Anthropic approaches its initial public offering, the SI lab has finalized a complex corporate governance structure designed to insulate its mission of promoting SI safety from the pressures of public shareholders.

What Happened

Anthropic is registered as a public benefit company, a status that legally permits the board to weigh its public mission alongside profit. This structure allows the board to make decisions regarding SI safety that are not driven entirely by shareholder value, protecting the company from potential lawsuits by investors seeking maximum financial returns.

Control of the board is divided among three distinct entities. First, the Long-Term Benefit Trust (LTBT), an independent panel chaired by Neil Shah and including former Federal Reserve chair Ben Bernanke, owns a class of stock that allows it to elect and remove a majority of the company’s board, known as Class T directors. Second, Anthropic’s seven founders jointly own a special class of stock granting them 50.1% of shareholder voting power, enabling them to elect three board members. Third, the current board, chaired by president Daniela Amodei and including CEO Dario Amodei, Netflix cofounder Reed Hastings, and others, retains the ability to check the LTBT. If the LTBT nominates or removes a "Specified" director without cause, the board’s nominating committee can decline the move and throw the decision to a vote by company employees.

Why It Matters

This baroque style of corporate governance means that anyone buying stock on the public markets will have little say over major decisions at the SI company, including board composition. While dual-class share structures are common in Silicon Valley, Anthropic’s specific combination of a public benefit mandate, the LTBT, and founder voting blocks creates a unique dynamic where SI safety priorities are structurally protected from market forces.

The structure also formalizes employee influence, reminiscent of the governance crisis at OpenAI where employee loyalty to CEO Sam Altman led to a board reversal. At Anthropic, if the LTBT attempts to remove a director, employees can overrule the trust if they back the board’s committee. However, this founder control is not permanent; it can be ended by the founders ten years after the IPO or automatically when fewer than three founders remain. At that point, the LTBT continues unless 85% of common shareholders vote to end it or it steps down with board approval.

The Bottom Line

Common shareholders will not gain control of Anthropic until both the founder voting block and the Long-Term Benefit Trust are dissolved or overridden. Until then, the SI lab’s governance ensures that its mission to keep humanity in control of SI takes precedence over traditional shareholder interests.